Intranasal naloxone administration for treatment of opioid overdose.
about
Application of human factors engineering (HFE) to the design of a naloxone auto-injector for the treatment of opioid emergencies.Incidence of Naloxone Redosing in the Age of the New Opioid Epidemic.Use of naloxone nasal spray 4 mg in the community setting: a survey of use by community organizations.Opiate addiction and overdose: experiences, attitudes, and appetite for community naloxone provision.Drugs, guns and cars: how far we have come to improve safety in the United States; yet we still have far to go.Use of Intranasal Naloxone by Basic Life Support Providers.Take-home naloxone treatment for opioid emergencies: a comparison of routes of administration and associated delivery systems.Opioid overdose prevention through pharmacy-based naloxone prescription program: Innovations in health care delivery.Comparison of a New Intranasal Naloxone Formulation to Intramuscular Naloxone: Results from Hypothesis-generating Small Clinical Studies.Basic and Advanced EMS Providers Are Equally Effective in Naloxone Administration for Opioid Overdose in Northern New England.Naloxone administration for suspected opioid overdose: An expanded scope of practice by a basic life support collegiate-based emergency medical services agency.Intranasal midazolam for rapid sedation of an agitated patient.Intranasal naloxone and related strategies for opioid overdose intervention by nonmedical personnel: a review.Community pharmacist knowledge, attitudes and confidence regarding naloxone for overdose reversal.Buprenorphine Treatment for Adolescents and Young Adults With Opioid Use Disorders: A Narrative Review.
P2860
Q28468357-20922472-86F9-4095-ABF1-8AD78A9A52D7Q38689393-BBF0583D-F414-4751-A65B-3BC2C5CB5EC7Q38769034-C4B38D21-AEAA-457A-80D8-2AE0F52FE54BQ38936820-F978F348-FA97-471F-8610-9BDBF027615EQ38965656-ACF47FE4-91CC-4205-A646-D91A8D1EDF02Q38976288-515A240F-69BC-4906-BC19-8BE3138EF680Q39411044-A06BD2D1-50C3-4033-8C84-03828F6A05FCQ39778821-7BC69BE8-CD46-40FF-A1AF-D12B9BB2E6F3Q41369342-CD7160E3-482C-4F69-BDAB-A875816480E0Q41986644-1BF8A106-6FD8-4170-8BEA-D1C9F237D3A0Q42059731-353E11A0-1DF0-48D3-946A-8D14941C24E4Q42145584-7612E516-C289-4C2F-98A9-691725EA8340Q42687927-9E4433C0-76DD-4BBC-99B4-AAC8CB7F5EC1Q48178385-27AAB703-2B81-41A0-85A7-B5F8E5BA34B2Q50062946-1A36B35A-C675-4A4D-A032-ACC7711EBE82
P2860
Intranasal naloxone administration for treatment of opioid overdose.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Intranasal naloxone administration for treatment of opioid overdose.
@ast
Intranasal naloxone administration for treatment of opioid overdose.
@en
type
label
Intranasal naloxone administration for treatment of opioid overdose.
@ast
Intranasal naloxone administration for treatment of opioid overdose.
@en
prefLabel
Intranasal naloxone administration for treatment of opioid overdose.
@ast
Intranasal naloxone administration for treatment of opioid overdose.
@en
P356
P1476
Intranasal naloxone administration for treatment of opioid overdose.
@en
P2093
Amanda Robinson
Daniel P Wermeling
P304
P356
10.2146/AJHP130798
P577
2014-12-01T00:00:00Z